Daniel Markowitz
Stock Analyst at Evercore ISI Group
(3.17)
# 1,106
Out of 5,148 analysts
30
Total ratings
56.52%
Success rate
1.25%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $250 → $260 | $200.17 | +29.89% | 3 | Feb 27, 2026 | |
| TMDX TransMedics Group | Maintains: Outperform | $155 → $170 | $147.00 | +15.65% | 2 | Feb 25, 2026 | |
| RGEN Repligen | Maintains: Outperform | $180 → $170 | $124.97 | +36.03% | 5 | Feb 25, 2026 | |
| GH Guardant Health | Maintains: In-Line | $105 → $110 | $92.23 | +19.27% | 4 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Outperform | $370 → $340 | $245.45 | +38.52% | 2 | Feb 19, 2026 | |
| TECH Bio-Techne | Maintains: In-Line | $62 → $68 | $57.82 | +17.61% | 4 | Feb 5, 2026 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $390 → $320 | $251.25 | +27.36% | 4 | Feb 3, 2026 | |
| RMBS Rambus | Maintains: Outperform | $126 → $119 | $98.88 | +20.35% | 3 | Feb 3, 2026 | |
| DXCM DexCom | Initiates: In-Line | $68 | $73.78 | -7.83% | 1 | Nov 25, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $64.81 | +92.87% | 2 | Oct 7, 2025 |
Natera
Feb 27, 2026
Maintains: Outperform
Price Target: $250 → $260
Current: $200.17
Upside: +29.89%
TransMedics Group
Feb 25, 2026
Maintains: Outperform
Price Target: $155 → $170
Current: $147.00
Upside: +15.65%
Repligen
Feb 25, 2026
Maintains: Outperform
Price Target: $180 → $170
Current: $124.97
Upside: +36.03%
Guardant Health
Feb 20, 2026
Maintains: In-Line
Price Target: $105 → $110
Current: $92.23
Upside: +19.27%
Insulet
Feb 19, 2026
Maintains: Outperform
Price Target: $370 → $340
Current: $245.45
Upside: +38.52%
Bio-Techne
Feb 5, 2026
Maintains: In-Line
Price Target: $62 → $68
Current: $57.82
Upside: +17.61%
West Pharmaceutical Services
Feb 3, 2026
Maintains: Outperform
Price Target: $390 → $320
Current: $251.25
Upside: +27.36%
Rambus
Feb 3, 2026
Maintains: Outperform
Price Target: $126 → $119
Current: $98.88
Upside: +20.35%
DexCom
Nov 25, 2025
Initiates: In-Line
Price Target: $68
Current: $73.78
Upside: -7.83%
Inspire Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $64.81
Upside: +92.87%